What are the diagnostic criteria for Polycystic Ovary Syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Polycystic Ovary Syndrome (PCOS)

PCOS is diagnosed when at least two of three criteria are present: oligo/anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound, after excluding other causes of androgen excess. 1

Core Diagnostic Criteria (Rotterdam Criteria)

The diagnosis requires any two of the following three features 1, 2:

  1. Oligo- or anovulation: Menstrual cycle length >35 days indicates chronic anovulation 1

  2. Clinical or biochemical hyperandrogenism:

    • Clinical signs: acne, hirsutism, male-pattern balding, clitoromegaly 1
    • Biochemical: Elevated total testosterone (TT) or free testosterone (FT) as first-line laboratory tests 1
  3. Polycystic ovarian morphology (PCOM): Detected on transvaginal ultrasound 1, 2

Ultrasound Diagnostic Thresholds

Follicle number per ovary (FNPO) ≥20 follicles is the gold standard ultrasonographic marker, with sensitivity of 87.64% and specificity of 93.74% 1, 3. This represents the most accurate diagnostic marker based on recent meta-analysis.

Alternative ultrasound markers when accurate follicle counting is not possible 3, 1:

  • Ovarian volume (OV) >10 mL as the threshold for increased ovary size 1
  • Follicle number per single cross-section (FNPS) 3

Technical specifications for optimal imaging 1:

  • Use transvaginal ultrasound with ≥8 MHz transducer frequency in adults
  • Do NOT use ultrasound as first-line investigation in adolescents (<17 years) due to poor specificity 1

Essential Clinical History and Physical Examination

Document the following specific elements 1:

  • Onset and duration of androgen excess signs (rapid onset suggests androgen-secreting tumor) 1, 4
  • Menstrual history: Cycle length, regularity, age at menarche 1
  • Medication review: Exogenous androgens, hormonal contraceptives, spironolactone 1
  • Lifestyle factors: Diet, exercise patterns, alcohol use, smoking 1
  • Family history: Cardiovascular disease, diabetes 1
  • Physical measurements: BMI and waist-hip ratio 1

Mandatory Differential Diagnosis Exclusions

Before confirming PCOS, you must rule out these conditions 1, 4:

High-priority exclusions (can mimic PCOS):

  • Non-classic congenital adrenal hyperplasia (NCCAH): Check basal or ACTH-stimulated 17-hydroxyprogesterone 1, 4
  • Cushing's syndrome: Look for buffalo hump, moon facies, hypertension, abdominal striae; screen with overnight dexamethasone suppression test or 24-hour urinary free cortisol 1, 4
  • Androgen-secreting tumors (ovarian or adrenal): Suspect with rapid onset, severe hyperandrogenism, and very high serum androgen levels 1, 4
  • Thyroid disease and hyperprolactinemia: Check TSH and prolactin levels 1, 4

Additional considerations 1:

  • Acromegaly and genetic defects in insulin action
  • Primary hypothalamic amenorrhea
  • Primary ovarian failure

Laboratory Screening Tests

First-line hormonal assessment 5:

  • Total testosterone
  • Free testosterone
  • DHEA-sulfate
  • 17-hydroxyprogesterone (to exclude NCCAH)

Metabolic screening (especially in obese patients) 1, 5:

  • Fasting glucose and insulin levels
  • Lipid profile
  • Screen all women with PCOS for type 2 diabetes and glucose intolerance 1

Emerging Diagnostic Markers

Anti-Müllerian Hormone (AMH) is being investigated as an alternative to ultrasound for PCOM detection, with significantly higher levels in PCOS patients 1, 6. However, AMH is not yet adequate for diagnosis due to lack of standardization across assays and absence of established cut-offs 1, 6.

Critical Diagnostic Pitfalls

Avoid these common errors:

  • Do not diagnose PCOS in adolescents based on ultrasound alone – polycystic ovarian morphology is common in normal adolescents 1, 6
  • Beware of medication effects: Spironolactone artificially lowers testosterone levels and improves menstrual regularity, masking diagnostic criteria 7. Ideally, conduct evaluation before initiating therapy or after a 2-4 week washout period 7
  • Ensure proper ultrasound technique: Use transvaginal approach with high-frequency transducer (≥8 MHz) for accurate follicle counting 1
  • Always exclude other causes of hyperandrogenism before confirming PCOS diagnosis – this is not optional 1, 4

Age-Specific Considerations

In adolescents (<20 years, at least 1 year post-menarche) 3:

  • Avoid ultrasound as primary diagnostic tool due to high false-positive rate 1
  • Rely more heavily on clinical and biochemical hyperandrogenism plus menstrual irregularity
  • More data needed to support ultrasonographic criteria in this age group 3

In adults (18-50 years) 3:

  • Full Rotterdam criteria apply
  • Transvaginal ultrasound is appropriate and recommended 1

References

Guideline

Diagnostic Criteria and Treatment Options for Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.

Best practice & research. Clinical obstetrics & gynaecology, 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2012

Research

A practical approach to the diagnosis of polycystic ovary syndrome.

American journal of obstetrics and gynecology, 2004

Guideline

Spironolactone's Impact on PCOS Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.